Keysight director plans $958K sale of 3,000 shares

Keysight Technologies, Inc. (KEYS) has a notice of proposed sale of common stock filed under Rule 144 on behalf of director Jean Nye McClung.

Rhea-AI Filing Summary

Keysight Technologies, Inc. (KEYS) has a notice of proposed sale of common stock filed under Rule 144 on behalf of director Jean Nye McClung. A total of 3,000 shares of Keysight common stock held at Fidelity Brokerage Services LLC are proposed for sale on or after 08/21/2026.

The shares originate from restricted stock that vested as compensation: 1,626 shares vested on 03/18/2022 and 1,374 shares vested on 03/17/2023, both issued by Keysight as compensation awards. The filing lists an aggregate market value of $957,660.00 for the 3,000 shares.

Key Figures

Shares proposed to be sold: 3,000 shares of common stock Aggregate market value: $957,660.00 Shares from 03/18/2022 restricted stock vesting: 1,626 shares +2 more

5 metrics

Shares proposed to be sold 3,000 shares of common stock Proposed sale under Rule 144

Aggregate market value $957,660.00 Value of 3,000 Keysight common shares proposed for sale

Shares from 03/18/2022 restricted stock vesting 1,626 shares Restricted stock vesting labeled as Compensation on 03/18/2022

Shares from 03/17/2023 restricted stock vesting 1,374 shares Restricted stock vesting labeled as Compensation on 03/17/2023

Proposed sale date 08/21/2026 Date tied to proposed sale of 3,000 shares

Key Terms

Rule 144, restricted stock, attorney-in-fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock financial

"Common | 03/18/2022 | Restricted Stock Vesting | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

attorney-in-fact regulatory

"as attorney-in-fact for Jean Nye"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for KEYS disclose?

The Form 144 reports a proposed sale under Rule 144 of 3,000 shares of Keysight Technologies, Inc. common stock, beneficially owned by director Jean Nye McClung, with an aggregate market value of $957,660.00 and a proposed sale date of 08/21/2026.

Who is selling KEYS shares under this Form 144 and in what capacity?

The notice covers shares for the account of Jean Nye McClung, identified as a director of Keysight Technologies, Inc. Fidelity Brokerage Services LLC is listed as the broker, and the form is signed by Daniel Tucci as attorney-in-fact for Jean Nye.

How many Keysight (KEYS) shares are proposed to be sold and on which market?

The filing states that 3,000 shares of Keysight common stock are proposed to be sold. The securities are listed for trading on the NYSE, and the filing ties the proposed sales to that market.

What is the origin of the KEYS shares being sold under Rule 144?

All 3,000 shares come from restricted stock that vested as compensation from Keysight: 1,626 shares from a 03/18/2022 restricted stock vesting and 1,374 shares from a 03/17/2023 restricted stock vesting, both labeled as Compensation.

What valuation is associated with the KEYS shares in this Form 144?

The Form 144 lists an aggregate market value of $957,660.00 for the 3,000 Keysight common shares proposed for sale, reflecting the filer’s stated valuation at the time of the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/21/2026 - 09:35 AM EDT Accepted by SEC EDGAR 08/21/2026 - 09:35 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001142618
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Keysight Technologies, Inc.
SEC File Number	001-36334
Address of Issuer	1400 FOUNTAINGROVE PARKWAY SANTA ROSA CALIFORNIA 95403
Phone	8774244536
Name of Person for Whose Account the Securities are To Be Sold	NYE JEAN MCCLUNG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3000	957660.00	170895368	08/21/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2022	Restricted Stock Vesting	Issuer			1626	03/18/2022	Compensation
Common	03/17/2023	Restricted Stock Vesting	Issuer			1374	03/17/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jean Nye
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)